RECOMBINATE 1000 IU
국가: 이스라엘
언어: 영어
출처: Ministry of Health
이 제품에 대한 일부 문서는 현재 사용할 수 없습니다. 고객 서비스에 요청을 보내면 가능한 빨리 알려 드리겠습니다.
요청을 보내십시오.
요청을 보내십시오.
유효 성분:
COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL
제공처:
TEVA MEDICAL MARKETING LTD.
ATC 코드:
B02BD02
약제 형태:
POWDER FOR SOLUTION FOR INJECTION
관리 경로:
I.V
Manufactured by:
BAXTER S.A., BELGIUM
치료 그룹:
COAGULATION FACTOR VIII
치료 징후:
The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.
승인 날짜:
2010-07-01
